5VET002 Veta K-1
- Manufacturer
- Best Formulations Inc.
- Effective date
- 2021-11-21
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 5
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:26:29
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
IMPORTANT
This is a bulk packaged product. It is not intended for use in its present form. Further processing is in accordance with all application standards and regulations. Storage conditions: 30% to 50% relative humidity at 59 degrees - 86 degrees F ( 15 degrees - 30 degrees C). Do not refrigerate.
Bulk Packaged Product Label Drug
Best Formulations 17758 Rowland Street City of Industry, CA 91748 (626) 912-9998
DESCRIPTION
PRODUCT: VIT. K-1 GEL CAPS
CODE: DR5005
SIZE: 5 Oval
LOT NO.: L11027
NET WEIGHT: 16.33 Lbs
COUNT: 23,000 Softgels
MFG DATE: 01 - 2012
BY: M.Z.
INGREDIENTS
Vitamin K-1 Phytonadione, Soybean Oil, Gelatin, Glycerin, Purified Water, FDandC Blue # 1, Titanium Dioxide
DRUG
IMPORTANT
This is a bulk packaged product. It is not intended for use in its present form. Further processing is in accordance with all application standards and regulations. Storage conditions: 30% to 50% relative humidity at 59 degrees - 86 degrees F ( 15 degrees - 30 degrees C). Do not refrigerate.
res
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PHYTONADIONE | ACTIVE INGREDIENT | A034SE7857 | 1 | |
| PHYTONADIONE | ACTIVE MOIETY | A034SE7857 | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| SOYBEAN OIL | INACTIVE INGREDIENT | 241ATL177A | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- 5VET002 Veta K-1
- PHYTONADIONE
- SOYBEAN OIL
- GELATIN
- GLYCERIN
- WATER
- FD&C BLUE NO. 1
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 66201-002 | 66201-002-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PHYTONADIONE | A034SE7857 | ACTIB |
| SOYBEAN OIL | 241ATL177A | IACT |
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CONCENTRATE / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION / SUBCUTANEOUS | 16 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, SUSPENSION / INTRAMUSCULAR | 1.3 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, CHEWABLE / ORAL | 24 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, SUGAR COATED / ORAL | NA | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET / ORAL | 46 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION / INTRACAVITARY | 0.05 ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, COATED / ORAL | 42.12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | POWDER, FOR SUSPENSION / ORAL | 1 mg/5ml | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, SUGAR COATED / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GRANULE, FOR SUSPENSION / ORAL | 143 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CREAM / TOPICAL | 0.01 %w/w | ||
| SOYBEAN OIL | SOYBEAN OIL | 241ATL177A | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 223 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, COATED PELLETS / ORAL | 65 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | PASTE, DENTIFRICE / DENTAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, EXTENDED RELEASE / ORAL | 1 mg | ||
| SOYBEAN OIL | SOYBEAN OIL | 241ATL177A | INJECTION / INTRAVENOUS | 10 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | PASTE / DENTAL | NA | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SOLUTION / DENTAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SOLUTION / RECTAL | 0.01 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, DELAYED RELEASE / ORAL | 1791 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 2 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | 13 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PHYTONADIONE | PHYTONADIONE | HF Acquisition Co LLC, DBA HealthFirst | 5686f34b-446a-00ae-e063-6394a90a6029 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Vitamin K1 | PHYTONADIONE | Hospira, Inc. | e8808230-2c44-44c6-8cab-8f29b6b34051 | 2026-08-09 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| PHYTONADIONE | PHYTONADIONE | Sun Pharmaceutical Industries, Inc. | 51c175dd-02f9-68d1-e063-6294a90a4b36 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| PHYTONADIONE | PHYTONADIONE | Amneal Pharmaceuticals Private Limited | ddd351d3-8b9e-482d-9ab8-f367ce1c3cc0 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| PHYTONADIONE | PHYTONADIONE | Orbicular Pharmaceutical Technologies Private Limited | d954e3d7-a4d5-4798-887d-7af916ff0181 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Major Pharmaceuticals | 54f23bc8-d8f3-40e8-a93d-3121cc581d54 | 2026-03-16 | Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Sagent Pharmaceuticals | 3d571642-3d3a-41ae-855e-304ae4fff459 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | GLENMARK PHARMACEUTICALS INC | 60e5abd1-e2fa-4a5e-b25b-3ec6cfdeed14 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Agnitio Inc. | 66ada4f8-c5a9-49f1-848f-e172416892a1 | 2025-12-01 | Adverse reactions | PHYTONADIONE |
| PHYTONADIONE | PHYTONADIONE | Henry Schein, Inc. | 1cf90be3-a744-4db5-999d-a84c67372304 | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| PHYTONADIONE | PHYTONADIONE | Henry Schein, Inc. | 0d971993-466c-46dd-bdd6-2e300173621e | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| phytonadione | PHYTONADIONE | Amneal Pharmaceuticals LLC | 2ce1dd90-11ad-4f74-af16-45b7e59f05da | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Alembic Pharmaceuticals Limited | 6ccb76ab-1549-4a47-a119-8059588ad83d | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Alembic Pharmaceuticals Inc. | b1e53422-c85d-4bb6-af4f-24934cc319b0 | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Coupler LLC | 3e4f86c4-7e89-c864-e063-6394a90a59af | 2025-09-08 | Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Xiromed LLC | a4b394e7-b766-824e-a8bf-f56808de76e1 | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Caplin Steriles Limited | 114b1330-6f03-476c-8678-8cd0da189bce | 2025-04-26 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Fresenius Kabi USA, LLC | 02a39690-38e6-42e9-9897-391c2df9e07e | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Cipla USA Inc. | 4bc2de7b-6564-4d77-8a65-6be57b706093 | 2025-01-07 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
| Phytonadione | PHYTONADIONE | Gland Pharma Limited | c375bfab-5a4b-40f3-a783-8372158af860 | 2024-12-12 | Boxed warning, Warnings, Adverse reactions | PHYTONADIONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

